Gondola Medical Technology

Gondola Medical Technologies SA is a Swiss based company that has developed the Gondola™ device, a proprietary medical device to treat motor symptoms of neurological and neurodegenerative conditions. It is effective in treating invalidating mobility problems caused by stroke or Parkinson’s disease. These symptoms do not have adequate response to currently available treatments. Device efficacy has been documented via clinical trials and peer-reviewed publications. Gondola™ bears CE mark and has been accepted by the US FDA in the “Breakthrough Devices Program”, a fast track procedure to expedite patients’ access to innovative medical devices that address unmet medical needs. FDA marketing authorization is expected in mid-2020. The device is protected by patents in USA, Canada, Europe, China, Israel, Japan, and other geographies